The team behind Rezo Therapeutics, a new biotech co-founded by a group of University of California, San Francisco, scientists including Natalia Jura, Kevan Shokat, Nevan Krogan, and industry veterans George Scangos and Norbert Bischofberger, was weighing if, and how, to finally come out of stealth mode after nearly five years of work.
